CDTXbenzinga

HC Wainwright & Co. Maintains Buy on Cidara Therapeutics, Raises Price Target to $35

Summary

No summary available.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on March 10, 2025 by benzinga